Use of Iodinated and Gadolinium-Containing Contrast Media in CKD
Authors:
- 19 October 2021
- book chapter
- Published by Springer Nature
- p. 395-409
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosisCell Death & Disease, 2011
- Incidence of Contrast-Induced Nephropathy after Contrast-Enhanced Computed Tomography in the Outpatient SettingClinical Journal of the American Society of Nephrology, 2010
- Iodixanol, Constriction of Medullary Descending Vasa Recta, and Risk for Contrast Medium–induced NephropathyRadiology, 2009
- Incidence and Outcomes of Contrast-Induced AKI Following Computed TomographyClinical Journal of the American Society of Nephrology, 2008
- The importance of residual renal function in dialysis patientsKidney International, 2006
- Universal Use of Nonionic Iodinated Contrast Medium for CT: Evaluation of Safety in a Large Urban Teaching HospitalAmerican Journal of Roentgenology, 2005
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsThe Lancet, 2000
- Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medullaKidney International, 1998
- Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis.American Journal of Roentgenology, 1994
- Early renal medullary hypoxic injury from radiocontrast and indomethacinKidney International, 1991